Cash Flow Statement

Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

bioAffinity Technologies (BIAF) Amortizatization of Intangibles (2022)

bioAffinity Technologies has reported Amortizatization of Intangibles over the past 1 years, most recently at $82679.0 for Q4 2022.

Quarterly Amortizatization of Intangibles changed N/A to $82679.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2022, changed N/A year-over-year, with the annual reading at $2.1 million for FY2022, 327.74% up from the prior year.
Amortizatization of Intangibles was $82679.0 for Q4 2022 at bioAffinity Technologies, down from $767693.0 in the prior quarter.
Over five years, Amortizatization of Intangibles peaked at $978217.0 in Q1 2022 and troughed at $82679.0 in Q4 2022.